Nicotine
Episodes exploring nicotine as a nootropic — cognitive benefits, acetylcholine mechanisms, dosing protocols, addiction research, and clinical trials on memory and focus.
Using low-dose nicotine (gum, pouches, or patches) as a cognitive enhancer for focus, attention, and memory - separate from smoking or tobacco use
Nicotine is one of the most effective acute cognitive enhancers available, improving attention, working memory, and reaction time. Separated from tobacco smoke, it's far less harmful than most people assume - though not risk-free.
If you try nicotine for cognitive enhancement, use the lowest effective dose (1-2mg), limit to 2-3 times per week maximum, and never use daily. The acute focus benefits are real, but so is the addiction potential with frequent use. Gum or pouches offer better control than patches for on-demand use. Be aware of ingredient concerns - some pouches contain microplastics or artificial sweeteners you may want to avoid.
Science & Mechanisms
Mechanisms:
- Binds to nicotinic acetylcholine receptors (nAChRs) in the brain
- Increases release of dopamine, norepinephrine, and acetylcholine
- Enhances attention, working memory, and processing speed
- Effects are acute (within minutes) and last 1-2 hours
- Upregulates nicotinic receptors with repeated use (tolerance/dependence pathway)
Key concepts:
- Nicotine ≠ tobacco - most harms of smoking come from combustion, not nicotine itself
- Dose-response curve is steep - more is not better, often worse
- Naive users (non-smokers) are more sensitive and need lower doses
- Half-life is ~2 hours, but metabolite cotinine lasts longer
- Receptor upregulation with daily use creates physical dependence
Evidence base:
- Consistent improvements in attention and reaction time across studies
- Memory enhancement documented, especially in attention-demanding tasks
- Most research conducted on smokers or for smoking cessation
- Limited direct research on low-dose cognitive enhancement in non-smokers
- Dave Asprey and other biohackers have popularized intermittent protocols
Limitations:
- Addiction potential is real - daily use leads to dependence
- Most studies not designed for the nootropic use case
- Individual response varies significantly
- Long-term effects of intermittent low-dose use not well-studied
- Cardiovascular effects (vasoconstriction, heart rate increase) may concern some users
Episodes
Nicotine without tobacco (patches, gum, pouches) can sharpen focus at 1-2mg doses. The key is intermittent use - max 2-3 times per week to avoid dependency. Daily use builds tol...
Nicotine genuinely enhances attention and memory, peaking in 15-30 minutes and lasting 1-2 hours. Addiction risk is real with frequent use. If you use it, avoid smoking and vapi...
I've never heard a podcast on nicotine that I was impressed with because tobacco is usually bashed, or if the podcast is about tobacco it is all about energy and the teacher asp...
Part 2 of Dave Asprey's nicotine masterclass covers real-world usage templates, tolerance management, and how biohackers use low-dose nicotine for cognition and Parkinson's prev...
Dave Asprey makes the case for microdosing nicotine at 1-2mg daily, citing Dr. Newhouse's Alzheimer's research and his own 15+ years of use for focus, energy, and neuroprotection.
Dave Asprey interviews David Renteln, co-founder and CEO of LUCY Nicotine and former Soylent co-founder, about nicotine as a misunderstood cognitive enhancement tool. They expla...
Dr. Bonnie Halpern-Felsher, a professor of pediatrics and developmental psychologist at Stanford, discusses the alarming rise of vaping among adolescents and teens, along with o...
Luke Storey interviews Nicco Magnotto, founder of NickNack, a clean tobacco-free nicotine lozenge company, about nicotine's underappreciated role as a cognitive enhancer. Magnot...
Leanne Vogel, holistic nutritionist and functional medicine practitioner, presents a solo deep-dive into nicotine as a standalone compound separate from smoking. Motivated by li...
Dr. Paul Newhouse, a physician and neuroscientist at Vanderbilt University who has studied the brain's cholinergic system for over 40 years, joins Liz Moody to discuss the thera...
Dave Asprey interviews pharmacist Nayan Patel about a breakthrough transdermal delivery system for glutathione that uses sugar-based dextrin technology to bypass the skin's fat ...